COVID-19 Shots Associated with Neuropsychiatric Disorders
A 2025 study published in the International Journal of Innovative Research in Medical Science examined whether mRNA COVID-19 shots are linked to neuropsychiatric conditions, raising questions about their potential to damage the brain and mental health. The researchers, most of which are affiliated with The Wellness Company and the McCullough Foundation, note that the mRNA […]
FDA Suspends Chikungunya Vaccine Over Safety Concerns
The U.S. Food and Drug Administration (FDA) announced on Aug. 22, 2025 that it has suspended the license for French drugmaker Valneva’s chikungunya vaccine, warning that its continued use “poses a danger to public health” following a risk–benefit analysis conducted by the agency’s Center for Biologics Evaluation and Research (CBER). The decision came after reports […]
CDC’s Been Hurting a Long Time
The firing of the 17 sitting members of the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) by Secretary of Health and Human Services (HHS) Robert F. Kennedy, Jr. on June 9, 2025 initiated a firestorm of criticism about the new direction the CDC is taking. There […]
CDC Sued for Untested Childhood Vaccine Schedule
Two former physicians have filed a lawsuit against the U.S. Centers for Disease Control and Prevention (CDC) for recommending the childhood vaccine schedule without proving safety. Currently, CDC officials recommend that children receive more than 70 doses of over a dozen vaccines.1 2 The plaintiffs in this historic lawsuit are Paul Thomas, MD, a former […]
Pfizer’s COVID-19 Shot Linked to Serious Damage to Eyes
A new peer-reviewed study out of Turkey has found that the Pfizer/BioNTech mRNA COVID-19 biologic (Comirnaty) may cause significant and measurable changes to eye health that, for some individuals, could contribute to long-term or even permanent vision complications. The study, published in Ophthalmic Epidemiology on July 14, 2025 tracked 64 patients over a 2.5-month period, […]
FDA, CDC Halt Use of Chikungunya Vaccine in Adults 60+ After Two Deaths Reported
On May 9, 2025, the U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) recommended a temporary pause in the use of Ixchiq, a live virus vaccine designed to prevent chikungunya virus infection, in adults aged 60 years and older. The recommendation follows reports of serious post-marketing adverse […]